3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
64
Breast Neoplasms
20
Kidney Neoplasms
19
Gastrointestinal Stromal Tumors
16
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
9
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
7
Brain Neoplasms
7
Colorectal Neoplasms
6
Neuroendocrine Tumors
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Thyroid Neoplasms
4
Stomach Neoplasms
4
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Thyroid Cancer, Papillary
3
Sarcoma
3
Pancreatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Kidney Diseases
3
Glioblastoma
3
Esophageal Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Astrocytoma
3
Adenoma, Islet Cell
3
Adenocarcinoma, Follicular
3
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
Paclitaxel
8
pembrolizumab
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Albumin-Bound Paclitaxel
6
Pemetrexed
4
Nivolumab
4
Irinotecan
4
Everolimus
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
vosaroxin
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
Sunitinib
×
Clear all
No trials found.